NBIX vs VMD · P/E 45, rev $1.77B vs P/E 28, rev $153.5M
Neurocrine Biosciences Inc (NBIX) versus Viemed Healthcare Inc (VMD) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Viemed Healthcare Inc (VMD) is a medical devices company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported VMD revenue for 2026-06-30 was $153.5M. Net income was $5.3M. VMD currently screens at market cap $403.7M and trailing P/E 28.5.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. VMD currently screens at market cap $403.7M and trailing P/E 28.5.
Not investment advice. Open the NBIX and VMD stock pages for the full models.
Not investment advice.